This is a historical report — it no longer reflects this drug's current status. Current status: Permanently Discontinued. View this drug's full profile page →

Shortage Avoided

BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP

STERIMAX INC

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP 7.5MG has been permanently discontinued (last updated October 27, 2026). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Check with your pharmacist

StatusShortage Avoided

Same-ingredient products on fileNone found

Affected strength7.5MG

Report last updated2024-08-12

Checked by MedShort2026-11-12

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02460645

Strength

7.5MG

Dosage Form

SOLUTION

Route

INTRASPINAL

Active Ingredient

BUPIVACAINE HYDROCHLORIDE

Tier

Unrated

Last Updated

2024-08-12

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP has 2 shortage/discontinuation reports on file — this is one of them.

2026-10-27

Permanently Discontinued

Business reasons

Other Products from STERIMAX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAZOLAMIDE FOR INJECTION, USP

500MG · DIN 02358328

ACETYLCYSTEINE SOLUTION USP

200MG · DIN 02538431

ACYCLOVIR SODIUM INJECTION

50MG · DIN 02456524

APRESOLINE

20MG · DIN 00723754

ARSENIC TRIOXIDE FOR INJECTION

1MG · DIN 02492768

AZITHROMYCIN FOR INJECTION USP

500MG · DIN 02483890